of bacteria — that is, a greater number of bacteria in any given volume of fluid or tissue — will decrease the effectiveness of antibiotics. Unfortunately, the implications of this phenomenon have not yet translated into clinical practice, even though it wasfirst recognized in 1945. For one ...
Management includes observation or antibiotics. Infectious mononucleosis : a highly contagious viral infection caused by the Epstein-Barr virus . The main method of transmission is the spread of infected saliva . Clinical manifestations of the condition include fever , tonsillar pharyngitis , and ...
stool, mucus) which is then sent to a lab for analysis. Here, traditional diagnostic techniques, such as the disk-diffusion test (see video below), will look at the growth of bacteria in the sample in the presence ofantibiotics. An antibiotic is considered...
MRSA is one of the world's biggest drug resistance threats, a bacterial species capable of thwarting multiple antibiotics. Additionally, MRSA—methicillin-resistant Staphylococcus aureus—is a noteworthy cause of nosocomial infections, frequently afflicting patients in hospital settings around the globe. ...
She decides to call for a microbiological specialist, who thinks it is too early to tell whether the antibiotics are effective or not and advises to ‘wait and see’. The next morning (1 June), Mads Jensen has difficulties breathing and his condition deteriorates rapidly. The physician’s ...
and P6-6 produce substances that are non-toxic. The use of substantially non-bactericidal substances in medical devices allows for the bacteria to remain in their planktonic form so that current antibiotics and immune responses can clear the infection. In addition, substances that prevent biofilm fo...
(synonyms of actinomycin D include dactinomycin, actinomycin IV, actinomycin I1, actinomycin X1, and actinomycin C1), all taxoids such as taxols, docetaxel, and paclitaxel, paclitaxel derivatives, all olimus drugs, macrolide antibiotics (such as without limitation rapamycin), FKBP-12 mediated mTOR...
In another embodiment, bioactive agents which may be released controllably or non-controllably released include, but are not limited to macrolide antibiotics including FKBP-12 binding agents. Exemplary bioactive agents of this class include sirolimus (rapamycin), tacrolimus (FK506), everolimus (certican...
In some embodiments, chemotherapeutic agents may be selected from any one or more of cytotoxic antibiotics, antimetabolities, anti-mitotic agents, alkylating agents, arsenic compounds, DNA topoisomerase inhibitors, taxanes, nucleoside analogues, plant alkaloids, and toxins; and synthetic derivatives thereof...
Illustrative drug substances that may be incorporated into and/or onto the ECM materials used in the invention include, for example, antibiotics, thrombus-promoting substances such as blood clotting factors, e.g. thrombin, fibrinogen, and the like. These substances may be applied to the ECM ...